| Assessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange program Mind Exchange Working Group, A Antinori, G Arendt, I Grant, S Letendre, ... Clinical Infectious Diseases 56 (7), 1004-1017, 2013 | 223 | 2013 |
| Effect of subcutaneous casirivimab and imdevimab antibody combination vs placebo on development of symptomatic COVID-19 in early asymptomatic SARS-CoV-2 infection: a randomized … MP O’Brien, E Forleo-Neto, N Sarkar, F Isa, P Hou, KC Chan, BJ Musser, ... Jama 327 (5), 432-441, 2022 | 106 | 2022 |
| COVID-19 symptoms at hospital admission vary with age and sex: results from the ISARIC prospective multinational observational study Infection 49 (5), 889-905, 2021 | 86 | 2021 |
| Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: a phase III randomized controlled trial J Sperl, G Horvath, W Halota, JA Ruiz-Tapiador, A Streinu-Cercel, ... Journal of hepatology 65 (6), 1112-1119, 2016 | 67 | 2016 |
| Safety, virologic efficacy, and pharmacokinetics of CT-P59, a neutralizing monoclonal antibody against SARS-CoV-2 spike receptor-binding protein: two randomized, placebo … JY Kim, YR Jang, JH Hong, JG Jung, JH Park, A Streinu-Cercel, ... Clinical Therapeutics 43 (10), 1706-1727, 2021 | 53 | 2021 |
| Efficacy and safety of regdanvimab (CT-P59): a phase 2/3 randomized, double-blind, placebo-controlled trial in outpatients with mild-to-moderate coronavirus disease 2019 A Streinu-Cercel, O Săndulescu, LL Preotescu, JY Kim, YS Kim, S Cheon, ... Open forum infectious diseases 9 (4), ofac053, 2022 | 42 | 2022 |
| Multidrug Resistant Klebsiella pneumoniae ST101 Clone Survival Chain From Inpatients to Hospital Effluent After Chlorine Treatment LI Popa, I Gheorghe, IC Barbu, M Surleac, S Paraschiv, L Măruţescu, ... Frontiers in microbiology 11, 610296, 2021 | 41 | 2021 |
| ISARIC-COVID-19 dataset: a prospective, standardized, global dataset of patients hospitalized with COVID-19 M Etienne, N Ettalhaoui, AG Everding, M Evers, I Fabre, M Fabre, ... Scientific data 9 (1), 454, 2022 | 37 | 2022 |
| The value of open-source clinical science in pandemic response: lessons from ISARIC A Abbas, SA Abdukahil, NN Abdulkadir, R Abe, L Abel, L Absil, S Acharya, ... The Lancet infectious diseases 21 (12), 1623-1624, 2021 | 37 | 2021 |
| Models for the indices of thermal comfort SC Adrian, C Sergiu, M Maria, SC Anca, M Monica Journal of Medicine and Life 1 (2), 148, 2008 | 36 | 2008 |
| Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19 C Kartsonaki, JK Baillie, NG Barrio, J Baruch, A Beane, L Blumberg, ... International journal of epidemiology 52 (2), 355-376, 2023 | 33 | 2023 |
| Efficacy and safety of CT-P59 plus standard of care: a phase 2/3 randomized, double-blind, placebo-controlled trial in outpatients with mild-to-moderate SARS-CoV-2 infection JS Eom, M Ison, A Streinu-Cercel, O Săndulescu, L Preotescu, Y Kim, ... | 30 | 2021 |
| Surveillance of pneumococcal diseases in Central and Eastern Europe M Ceyhan, R Dagan, A Sayiner, L Chernyshova, EÇ Dinleyici, ... Human vaccines & immunotherapeutics 12 (8), 2124-2134, 2016 | 30 | 2016 |
| Type-specific herpes simplex virus-1 and herpes simplex virus-2 seroprevalence in Romania: comparison of prevalence and risk factors in women and men V Arama, AS Cercel, R Vladareanu, C Mihai, R Mihailescu, J Rankin, ... International Journal of Infectious Diseases 14, e25-e31, 2010 | 30 | 2010 |
| Euroguidelines in Central and Eastern Europe (ECEE) conference and the Warsaw Declaration–a comprehensive meeting report JD Kowalska, C Oprea, S De Witt, A Pozniak, D Gökengin, M Youle, ... Hiv medicine 18 (5), 370-375, 2017 | 26 | 2017 |
| A randomized clinical trial of regdanvimab in high-risk patients with mild-to-moderate coronavirus disease 2019 JY Kim, O Săndulescu, LL Preotescu, NE Rivera-Martínez, M Dobryanska, ... Open forum infectious diseases 9 (8), ofac406, 2022 | 22 | 2022 |
| Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon‐based therapy … M Buti, R Flisiak, JH Kao, WL Chuang, A Streinu‐Cercel, F Tabak, ... Journal of viral hepatitis 22 (7), 596-606, 2015 | 21 | 2015 |
| Treatment with lamivudine and entecavir in severe acute hepatitis B A Streinu-Cercel, O Sandulescu, M Stefan Indian Journal of Medical Microbiology 34 (2), 166-172, 2016 | 20 | 2016 |
| Assessment of knowledge, attitudes and perceptions regarding Ebola disease in healthcare workers from a tertiary care hospital in Romania D Piţigoi, O Săndulescu, T Ionescu, B Niţescu, M Niţescu, ... Public Health 164, 7-15, 2018 | 19 | 2018 |
| Microbiologic safety of the transareolar approach in breast augmentation DM Jianu, O Săndulescu, A Streinu-Cercel, I Berciu, A Blidaru, ... Aesthetic Surgery Journal 36 (1), 51-57, 2016 | 19 | 2016 |
